Interestingly, about 20% of ARMS do not present FOXO1 rearrangements and are considered to be ‘fusion-negative’ (FN)-RMS, that have a clinical course similar to ERMS. This evidence concerns the gene FOXO1 and embryonal rhabdomyosarcoma.